Sangui Biotech International, Inc. reported earnings results for the full year ended June 30, 2022. For the full year, the company reported net loss was USD 0.05931 million compared to USD 0.19889 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% | -.--% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 448K | |
+1.50% | 42.75B | |
+47.70% | 41.61B | |
+12.40% | 41.34B | |
-8.83% | 26.59B | |
+6.80% | 25.49B | |
-23.07% | 18.12B | |
+30.04% | 12.24B | |
-2.26% | 11.76B | |
+8.63% | 11B |
- Stock Market
- Equities
- SBH Stock
- News Sangui Biotech International, Inc.
- Sangui Biotech International, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022